Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial

Journal of Clinical Oncology(2023)

引用 0|浏览11
暂无评分
摘要
Adjuvant canakinumab did not increase disease-free survival in resected non–small-cell lung cancer.
更多
查看译文
关键词
lung cancer,canakinumab,adjuvant therapy,randomized clinical trial,small-cell,double-blind
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要